Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Pharmacology > GI Drugs > Flashcards

GI Drugs Flashcards

1
Q

Aluminum Hydroxde

A

Antacid
MOA: neutralization of low gastric pH protects esophageal mucosa from reflux corrosion
SE: constipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Magnesium Hydroxide

A

Antacid
MOA: neutralization of low gastric pH protects esophageal mucosa from reflux corrosion
SE: osmotic diarrhea (can become life threatening if someone abuses the drug)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Calcium Carbonate

A

Antacid
MOA: neutralization of low gastric pH protects esophageal mucosa from reflux corrosion
SE: CO2 causes belching and can lead to metabolic alkalosis (milk alkali syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Antacid Drug Interactions

A

Decreased absorption of coadministgered tetracyclines, fluoroquinolones, itraconazole and iron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

H2 Receptor Antagonist (names)

A

Prototype: Cimetidine

2nd generation: Ranitidine, Famotidine, Nizatidine (no anti-adrogenic or CNS adverse effects)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

H2 Antagonists

A

MOA: selective competitive inhibition at the parietal H2 Gs receptor
Effect: suppress basal gastric acid secretion w/ modest effect on meal stimulated secretion
Use: GERD, PUD, nonulcer dyspepsia, prophylaxis against stress-related gastritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cimetidine SEs

A

Sx’s: gynecomastia, galactorrhea, male impotence (acts as nonsteroidal anti-androgen and prolactin stimulant); confusion, dizziness and HAs; B12 deficiency and myelosuppression in long term use
Interactions: CYP450 inhibition causing increased serum concentration of Warfarin, Diazepam and Phenytoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Proton Pump inhibitors

A

MOA: irreversibly bind and inhibit H-K ATPase in gastric parietal cells
Effect: suppress basal and meal stimulated gastric acid production
Use: pts that fail 2x daily H2RA therapy, severe GERD, PUD (H. pylori, NSAID ulcers), gastrinoma, nonulcer dyspepsia,
SEs: diarrhea, abd pn, HA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Proton Pump Inhibitors (names)

A

“-prazole” drugs

Omeprazole / Esomeprazole / Lansoprazole / Rabeprazole / Pantoprazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Omeprazole SEs

A

CYP450 inhibition, will inhibit metabolism of Warfarin, Diazepam and Phenytoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CYP2C19 inhibitors

A

Omeprazole / Esomeprazole / lansoprazole

*Clopidogrel requires CYP2C19 to convert it to active form so these drugs are CI in a pt taking Clopidogrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

H. pylori Eradication

A

Triple therapy (10-14d): Clarithromycin + Amoxicillin + PPI orrrr Clarithromycin + Metronidazole + PPI

Quadruple therapy (14d):
Bismuth Subsalicylate + Metronidazole + Tetracycline + PPI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Misoprostol

A

PGE1 analog
MOA: binds EP3 receptor stimulating Gi pathway
Effect: decreased gastric acid secretion, stimulates mucus and bicarbonate secretion, enhances mucosal blood flow
Use: prevention of NSAID-induced ulcers; diarrhea, abd pn
*CI in pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Sucralfate

A

Salt of sucrose + sulfate aluminum hydroxide
MOA: forms viscous paste that binds selectively to ulcers forming a physical barrier
Effect: stimulates mucosal prostaglandin and HCO3- secretion
Use: initial management of GERD in pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Bismuth Subsalicylate

A

Use: suppresses H. pylori
SE: dark stools, salicylate toxicity in combo w/ other salicylate products
CI: pts w/ ESRD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Prokinetic Agents

A

M1 agonists
Effect: enhance contractions in relatively uncooradinated fashion that produces little or no net propulsive activity
(Bethanechol / Neostigmine - not currently indicated for tx GI motility disorders)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Erythromycin

A

Motility receptor agonist
Effect: downregulation of motility receptors leading to early tolerance so its use is limited to short courses
Use: DM gastroparesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Cisapride

A

MOA: 5-HT4 agonist, 5-HT3 antagonist, direct smooth muscle stimulant
Use: was used for GERD and gastroparesis (no longer used in US bc it has potential to cause ventricular arrhythmias)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Metoclopramide

A

MOA: 5-HT4 agonist, vagal and central 5-HT3 antagonist, DA antagonist
Effect: increases LES tone, stimulates natural and small intestinal contractions
Use: gastroparesis, anti-emetic, previously used for GERD sx relief
SE: extrapyramidal effects d/t DA antagonism (more common in young ppl @ high doses), galactorrhea by blocking inhibitory effect of DA on prolactin release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Scopolamine

A

Antimuscarinic

Use: prevention and tx of motion sickness, post-op N/V

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

H1 Antagonists

A

Diphenhydramine / Meclizine / Cyclizine
MOA: act on vestibular afferents as well as brainstem
Use: motion sickness and post-op emesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

5-HT3 Antagonists

A

Ondansetron / Granisetron
MOA: antagonize receptors in vagal afferents, STN, CTZ and AP
Use: DOC for prophylaxis against chemo induced N/V, hyperemesis gravidarum, post-op N
SE: constipation, diarrhea, HA< lightheadedness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Arepitant

A

NK1 antagonist
MOA: antagonist of NK1 receptors for substance P
Use: prophylaxis against delayed cancer induced N/V
Administration: PO incombo w/ dexamethasone and 5-HT3 receptor antagonist
Metabolism: CYP3A4 metabolism and may affect metabolism of Warfarin and oral contraceptives

24
Q

Promethazine / Droperidol

A

D2 antagonists
MOA: D2 antagonism at CTZ
Use: motion sickness
SE: extrapyramidal effects

25
Dexamethasone / Methylprednisone
Corticosteroids Effect: suppression of peritumoral inflammatoin and prostaglandin production Use: adjuvants in tx of nause in pt's w/ metastatic ca
26
Dronabinol
Cannabinoid MOA: stimulates CB1 subtype of cannabinoid receptors on neurons in/around vomiting center in brainstem Use: prophylactic in pt's receiving chemo when other meds arent effective SEs: palpitations, tachycardia, vasodilation, hypotension, conjunctival injection, paranoid rxns
27
Lorazepam / Alprazolam / Diazepam
Effect: facilitate GABAa action in CNS by increasing frequency of Cl- channel opening Use: adjuncts d/t sedative, amnesiac, anti-anxiety effects SE: CNS depression and dependence
28
Methylcellulose / Psyllium / Bran
Bulk-forming laxatives MOA: nondigestible colloids absorb water to form bulky soft jelly that distended the colon to promote peristalsis CI: immobile pt's and those in long-term opioids therapy
29
Castor Oil
MOA: directly stimulate enteric nervous system to increase motility Metabolism: broken down to ricinoleic acid in small intestine CI: pregnancy (bc it may cause uterine contractions)
30
Senna
Stimulant laxative | SE: chronic use may lead to melanosis coli (brown pigment of colonic mucosa)
31
Docusate / Glycerine
Stool softener | MOA: surfactants which allow water to penetrate and soften formed stool in the bowel
32
Mineral Oil
Lubricant laxative | CI: not given with Ducosate as mineral oil will be absorbed into stool thereby negating its laxative effect
33
Osmotic Laxatives
Lactulose / Magnesium Hydroxide / Magnesium Sulfate | MOA: nonabsorbable sugars or slots exert osmotic pull to retain water
34
Lactulose
Metabolized by colonic bacteria and can lead to severe flats w/ cramping
35
Magnesium Salts
Shouldn't be used fro prolonged periods in persons w/ renal insufficiency bc they may cause hypermagnesemia
36
Polyethylene Glycol (PEG)
Osmotic laxative MOA: water soluble polymer that generates high osmotic pressure in gut lumen Use: complete bowel prep before GI endoscopy, preferred for management of chronic constipation
37
Lubiprostone
MOA: stimulates type 2 Cl- channels of small intestine Effect: increases secretion of Cl- resulting in 👆🏽intestinal mobility Use: chronic constipation and IBS w/ predominant constipation SE: diarrhea CI: children
38
Alvimopan / Methylnaltrexone
Selective mu-opioid receptor antagonists MOA: dont cross BBB so act at level of the gut to maintain normal motility in pt's w/ acute or chronic use of opioid analgesics
39
Loperamide
``` Opioid agonist MOA: activates present-tic mu-opioid receptors in entered nervous system to inhibit ACh release and decreases gut peristalsis Use: IBS w/ diarrhea predominance *low potential for addiction CI: children and pt's w/ severe colitis ```
40
Dioxyphenolate
Opioid agonist MOA: activates present-tic mu-opioid receptors in entered nervous system to inhibit ACh release and decreases gut peristalsis *can cross CNS at higher doses CI: children and pt's w/ severe colitis
41
Octreotide
Somatostatin analog Effect: decrease pancreatic exocrine fxn Use: secretory diarrhea d/t neuroendocrine tumors, diarrhea 2° to vagotomy, dumping syndrome, short bowel syndrome, AIDS SE: steatorrhea (can lead to fat-soluble vitamin deficiency), gallstones (d/t decreased gallbladder contractility)
42
Bismuth Subsalicylate
MOA: coating and salicylate component Effect: decreases fluid secretion in the enteric trace Use: traveler's diarrhea
43
Aminosalicylates
Sulfasalazine / Balsalazide / Mesalamine MOA: 5-aminosalicylates acid (5-ASA) at high concentrations at target sites given PO or suppository/enema depending on the site of dz Use: long term maintenance of IBD remission
44
Sulfasalazine
5-ASA linked to sulfapyridine by an ago bond (Only partially absorbed in jejunum after PO administration) SE: HA, arthralgia, myalgia, BM suppression, HS rxns
45
Balsalazide
5-ASA linked to inert unabsorbed carrier molecule | *delivers max amts to colon
46
Mesalamine
5-ASA packaged in microgranules taht release the active drug into desired portion of gut
47
Glucocorticoids
Prednisone / Prednisolone / Budesonide Effects: interaction w/ intracellular glucocorticoid response elements, inhibition of phospholipase A2 and COX, inhibition of NF-κB
48
Prednisone / Predisonolone
Intermediate duration of action which allows for once daily dosing
49
Hydrocortisone
Administered via enema for sigmoid and rectal iBD flares
50
Budesonide
High rate of first pass metabolism when given PO which decreases the rate of systemic SEs compared to other systemic corticosteroids
51
Mercaptopurine / Azathioprine
Immunosuppressive purines MOA: steroid sparing effect Use: IBD remission SE (toxicity): N/V, hepatotoxicity and BM suppression CI: administered w/ allopurinol bc it reduces xanthine oxide activity which can increase serum concentrations of these purines
52
Methotrexate
MOA: inhibits dihydrofolate reductase to decrease thymidine and purine production Effect: reduces IL-1 effects SE: BM suppression, megaloblastic anemia, mucositis (folate supplementation is recommended)
53
Anti-TNF-α Drugs
Infliximab / Adalimumab MOA: bind and inactivate TNF Effect: suppress pro-inflammatory response Use: acute and chronic IBD
54
Infliximab
Use: moderate-severe colitis that isn't responsive to Mesalamine or steroids
55
Natalizumab
Anti-integrin MOA: monoclonal Ab targeting integrity on circulating inflammatory cells Effect: disruption of leukocyte vascular wall adhesion and subsequent tissue migration Use: moderate-severe unresponsive Crohn's dz SE: infusion rxns, opportunistic infections, reactivation of JC virus resulting in PML
56
Pancrelipase
MOA: combination of amylase, lipase and proteases given PO with each meal Use: exocrine pancreas insufficiency (CF, chronic pancreatitis) SE: diarrhea, abd pn, hyperuricosuria, renal stones, colic strictures
57
Alosetron
5-HT3 antagonist | Use: diarrhea IBS

Pharmacology (27 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions